In March 2025, the company announced new designs for any direct-to-shopper supplying of its Wegovy weight loss drug. The company proven a brand new pharmacy, named NovoCare, which might charge consumers $499 per month for access to the drug, lower than half the price of the drug by way of other pharmaceutical distribution networks.[53]inflammation